Laurus Labs acquires additional stake in Laurus Bio

21 Nov 2023 Evaluate

Laurus Labs has completed the acquisition of balance 8,333 equity shares from the promoter group shareholders of Laurus Bio on November 20, 2023. With this acquisition the Company holds 87.59% shareholding (on fully diluted basis) in Laurus Bio.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1012.65 -5.55 (-0.55%)
04-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1818.60
Dr. Reddys Lab 1277.00
Cipla 1521.20
Zydus Lifesciences 935.20
Lupin 2091.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×